Drug Information

Drug General Information
Drug ID
D01NTI
Former ID
DNC005311
Drug Name
N*2*-Benzyl-N*6*-cyclohexyl-9H-purine-2,6-diamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527647]
Formula
C18H22N6
Canonical SMILES
C1CCC(CC1)NC2=NC(=NC3=C2NC=N3)NCC4=CC=CC=C4
InChI
1S/C18H22N6/c1-3-7-13(8-4-1)11-19-18-23-16-15(20-12-21-16)17(24-18)22-14-9-5-2-6-10-14/h1,3-4,7-8,12,14H,2,5-6,9-11H2,(H3,19,20,21,22,23,24)
InChIKey
NPPHTZNKBUCRPG-UHFFFAOYSA-N
PubChem Compound ID
15366659
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Inhibitor [527647]
Reactome Adenosine P1 receptors
G alpha (i) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, Other
References
Ref 527647J Med Chem. 2005 Jul 28;48(15):4910-8."Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.
Ref 527647J Med Chem. 2005 Jul 28;48(15):4910-8."Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.